JTCVS Open (Jun 2022)

Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapyCentral Message

  • Whitney S. Brandt, MD,
  • Bryan F. Meyers, MD, MPH

Journal volume & issue
Vol. 10
pp. 393 – 394

Abstract

Read online

No abstracts available.